Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Fda crawled time : 19:00 save search
Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy
Published: 2024-04-01 (Crawled : 19:00) - biospace.com/
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
|
| O: 1.78%
H: 1.13%
C: 0.11%
fda clearance therapy
FDA Approves Treatments for Anemia in Chronic Kidney Disease, Hepatitis
Published: 2024-03-29 (Crawled : 19:00) - biospace.com/
SNY | News | $46.385 2.19% 3M
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $107.4 2.02% 6.4M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $147.895 1.48% 5.8M
|
Health Technology
| Email alert
Add to watchlist
PRGO | $30.625 2.29% 640K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
fda hepatitis kidney anemia
U.S. FDA Approves Broad New Labels for NEXLETOL® and NEXLIZET® to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use
Published: 2024-03-22 (Crawled : 19:00) - globenewswire.com
ESPR | $1.94 3.74% 3.61% 7.3M
|
Health Technology
| Email alert
Add to watchlist
nexletol fda heart cardiovascular
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
Published: 2024-03-22 (Crawled : 19:00) - globenewswire.com
IVVD | $2.3 -2.13% 840K
|
Manufacturing
| Email alert
Add to watchlist
vyd222 covid-19 fda authorization
U.S. FDA Oncologic Drugs Advisory Committee recommends CARVYKTI® (ciltacabtagene autoleucel) for the earlier treatment of patients with relapsed or refractory multiple myeloma
Published: 2024-03-15 (Crawled : 19:00) - prnewswire.com
JNJ | News | $147.895 1.48% 5.8M
|
Health Technology
| Email alert
Add to watchlist
carvykti fda treatment
FDA Adcomm Unanimously Votes in Favor of J&J’s Carvykti Early in Multiple Mye...
Published: 2024-03-15 (Crawled : 19:00) - biospace.com/
JNJ | News | $147.895 1.48% 5.8M
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
fda carvykti
Sandoz receives FDA approval for first and only denosumab biosimilars
Published: 2024-03-05 (Crawled : 19:00) - globenewswire.com
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.46%
H: 1.3%
C: 0.44%
fda first approval
FDA Decisions: CMC Issues Thwart Venatorx and Melinta’s Urinary Tract Infection Antibiotic
Published: 2024-02-23 (Crawled : 19:00) - biospace.com/
PRGO | $30.625 2.29% 640K
|
Health Technology
|
| O: 0.22%
H: 0.85%
C: 0.85%
JNJ | News | $147.895 1.48% 5.8M
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
ABT | News | $107.4 2.02% 6.4M
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: 0.97%
H: 0.0%
C: 0.0%
fda infection
Coherus and Junshi Biosciences Announce FDA Approval of LOQTORZI™ (toripalimab-tpzi) in All Lines of Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)
Published: 2023-10-27 (Crawled : 19:00) - globenewswire.com
CHRS | $2.06 3.0% 2.91% 2.9M
|
Health Technology
| Email alert
Add to watchlist
SURF | $1.07 -0.93% -1.41% 0
|
Health Technology
| Email alert
Add to watchlist
fda approval treatment
Catalyst Pharmaceuticals Reports FDA Approval of AGAMREE® (vamorolone) for Duchenne Muscular Dystrophy Granted to Santhera Pharmaceuticals
Published: 2023-10-26 (Crawled : 19:00) - globenewswire.com
CPRX | $15.3 -0.26% 1.3M
|
Health Technology
|
| O: -0.22%
H: 0.0%
C: -10.48%
agamree fda granted approval pharmaceuticals duchenne
ContraFect Announces FDA Clearance of CF-370 IND Application to Proceed With Phase 1 Clinical StudyCF-370 is the first engineered lysin therapeutic targeting Gram-negative pathogens allowed to enter a human trial
Published: 2023-10-16 (Crawled : 19:00) - biospace.com/
CFRX | $0.05 0.0% 910K
|
Health Technology
|
| O: 17.89%
H: 0.0%
C: -29.19%
cf-370 fda clearance application trial pathogens
NRx Pharmaceuticals Announces FDA Permission to Proceed on Investigational New Drug (IND) Application for NRX-101 to Treat Chronic Pain
Published: 2023-10-02 (Crawled : 19:00) - biospace.com/
NRXP 1 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: 4.81%
H: 5.72%
C: 5.36%
nrx-101 fda drug permission treat pharmaceuticals application
Calliditas Therapeutics granted orphan drug designation by the FDA for the treatment of Alport syndrome with setanaxib
Published: 2023-09-27 (Crawled : 19:00) - biospace.com/
CALT | News | $17.65 3.8K
|
Health Technology
|
| O: 2.26%
H: 1.71%
C: -0.54%
fda drug granted treatment designation therapeutics
Mallinckrodt Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate Capsules and Launches Product Used to Treat Attention-Deficit/Hyperactivity Disorder (ADHD)
Published: 2023-08-31 (Crawled : 19:00) - biospace.com/
MNKPF | $17.25
|
n/a
| Email alert
Add to watchlist
MNK | $0.3402 -0.06% 540K
|
n/a
| Email alert
Add to watchlist
MNKKQ | $0.02
|
Manufacturing
| Email alert
Add to watchlist
fda approval treat
Reglagene gets crucial TCA Orange County funding for FDA brain cancer therapy studies
Published: 2023-08-01 (Crawled : 19:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
fda cancer funding therapy
AVITA Medical Announces FDA Approval of RECELL for Skin Repigmentation in Vitiligo Patients
Published: 2023-06-16 (Crawled : 19:00) - globenewswire.com
AVHHL | $3.203 -18.83% 650
|
n/a
| Email alert
Add to watchlist
RCEL | $8.59 -3.16% 270K
|
Health Technology
| Email alert
Add to watchlist
fda approval recell medical skin
FDA Permits Marketing of First COVID-19 At-Home Test Using Traditional Premarket Review Process
Published: 2023-06-06 (Crawled : 19:00) - fda.gov
HLTH | $0.1479 4.15% 3.99% 410K
|
|
| O: -0.96%
H: 0.15%
C: -9.39%
covid-19 fda test review
Astellas' VEOZAH™ (fezolinetant) Approved by U.S. FDA for Treatment of Vasomotor Symptoms Due to Menopause
Published: 2023-05-12 (Crawled : 19:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K
|
Health Technology
| Email alert
Add to watchlist
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
| Email alert
Add to watchlist
fda approved treatment
Getting Smarter: FDA Publishes Draft Guidance on Predetermined … – Ropes & Gray LLP
Published: 2023-05-02 (Crawled : 19:00) - spacfeed.com
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: 0.71%
H: 0.0%
C: 0.0%
fda
Magnolia Medical Expands Steripath® Micro Initial Specimen Diversion Device® (ISDD®) Product Family with New FDA 510(k) Clearance
Published: 2023-04-11 (Crawled : 19:00) - biospace.com/
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: 0.2%
H: 0.59%
C: -0.41%
steripath fda clearance medical
Gainers vs Losers
| 63% | 37% |
Top 10 Gainers
AGBA | News | $1.305 226.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
INSG | $3.03 25.21% 330K
|
Electronic Technology
KNW 4 | $0.59 -0.71% 18.64% 27K
|
Manufacturing
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
ASNS | $0.828 21.75% 17.86% 18K
|
UONE | $2.36 19.8% 16.53% 75K
|
Consumer Services
Your saved searches
Save your searches and get alerts when important news are released.